Free Trial
NASDAQ:RKDA

Arcadia Biosciences (RKDA) Stock Price, News & Analysis

Arcadia Biosciences logo
$1.12 -0.04 (-3.04%)
As of 11:28 AM Eastern

About Arcadia Biosciences Stock (NASDAQ:RKDA)

Advanced

Key Stats

Today's Range
$1.09
$1.15
50-Day Range
$1.05
$2.16
52-Week Range
$0.89
$6.71
Volume
7,149 shs
Average Volume
31,134 shs
Market Capitalization
$2.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Arcadia Biosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
7th Percentile Overall Score

RKDA MarketRank™: 

Arcadia Biosciences scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Arcadia Biosciences has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Arcadia Biosciences has only been the subject of 1 research reports in the past 90 days.

  • Read more about Arcadia Biosciences' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Arcadia Biosciences is -0.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Arcadia Biosciences is -0.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Arcadia Biosciences has a P/B Ratio of 0.48. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Arcadia Biosciences' valuation and earnings.
  • Percentage of Shares Shorted

    0.08% of the float of Arcadia Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Arcadia Biosciences has a short interest ratio ("days to cover") of 0.14, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Arcadia Biosciences has recently increased by 72.06%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Arcadia Biosciences does not currently pay a dividend.

  • Dividend Growth

    Arcadia Biosciences does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 1 news article for Arcadia Biosciences this week, compared to 1 article on an average week.
  • MarketBeat Follows

    1 people have added Arcadia Biosciences to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Arcadia Biosciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    8.20% of the stock of Arcadia Biosciences is held by insiders.

  • Percentage Held by Institutions

    17.73% of the stock of Arcadia Biosciences is held by institutions.

  • Read more about Arcadia Biosciences' insider trading history.
Receive RKDA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arcadia Biosciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RKDA Stock News Headlines

ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel
See More Headlines

RKDA Stock Analysis - Frequently Asked Questions

Arcadia Biosciences' stock was trading at $1.98 at the beginning of the year. Since then, RKDA shares have decreased by 41.9% and is now trading at $1.15.

Arcadia Biosciences, Inc. (NASDAQ:RKDA) released its earnings results on Thursday, March, 26th. The basic materials company reported ($0.98) EPS for the quarter, missing the consensus estimate of ($0.66) by $0.32. The basic materials company had revenue of $0.90 million for the quarter, compared to analysts' expectations of $1.40 million. Arcadia Biosciences had a positive trailing twelve-month return on equity of 37.36% and a negative net margin of 48.15%.

Arcadia Biosciences's stock reverse split on Wednesday, January 24th 2018.The 1-20 reverse split was announced on Tuesday, January 23rd 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, January 23rd 2018. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Arcadia Biosciences (RKDA) raised $66 million in an initial public offering on Friday, May 15th 2015. The company issued 8,200,000 shares at $8.00 per share. Credit Suisse, J.P. Morgan and Piper Jaffray acted as the underwriters for the IPO.

Shares of RKDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Arcadia Biosciences investors own include NVIDIA (NVDA), Meta Platforms (META), PayPal (PYPL), GE Aerospace (GE), Arista Networks (ANET), Advanced Micro Devices (AMD) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
3/26/2026
Today
5/07/2026
Next Earnings (Estimated)
5/07/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Agriculture
Current Symbol
NASDAQ:RKDA
CIK
1469443
Employees
60
Year Founded
2002

Profitability

EPS (Trailing Twelve Months)
($1.72)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.34 million
Net Margins
-48.15%
Pretax Margin
-47.98%
Return on Equity
37.36%
Return on Assets
23.95%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.09
Quick Ratio
2.50

Sales & Book Value

Annual Sales
$4.86 million
Price / Sales
0.47
Cash Flow
$1.25 per share
Price / Cash Flow
0.89
Book Value
$2.39 per share
Price / Book
0.47

Miscellaneous

Outstanding Shares
2,060,000
Free Float
1,888,000
Market Cap
$2.30 million
Optionable
Not Optionable
Beta
0.52

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:RKDA) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners